Anti-c-Myb (phospho S11) 抗体 [EP769Y] (ab45150)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EP769Y] to c-Myb (phospho S11)
- Suitable for: WB, IHC-P, IP, Dot blot
- Reacts with: Human
Related conjugates and formulations
製品の概要
-
製品名
Anti-c-Myb (phospho S11) antibody [EP769Y]
c-Myb 一次抗体 製品一覧 -
製品の詳細
Rabbit monoclonal [EP769Y] to c-Myb (phospho S11) -
由来種
Rabbit -
アプリケーション
適用あり: WB, IHC-P, IP, Dot blotmore details
適用なし: Flow Cyt -
種交差性
交差種: Human -
免疫原
Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.
-
ポジティブ・コントロール
- WB: Ramos, Molt-4, and HL-60 cell lysate. HeLa cell lysate untreated and treated with lambda phosphatase. IHC-P: Human cervical carcinoma tissue. IP: MOLT-4.
-
特記事項
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle. -
バッファー
pH: 7.20
Preservative: 0.01% Sodium azide
Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.05% BSA -
Concentration information loading...
-
精製度
Protein A purified -
ポリ/モノ
モノクローナル -
クローン名
EP769Y -
アイソタイプ
IgG -
研究分野
関連製品
-
Alternative Versions
-
ChIP Related Products
-
Compatible Secondaries
-
Isotype control
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab45150の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
WB | (1) |
1/1000 - 1/5000. Predicted molecular weight: 72 kDa.
|
IHC-P |
Use at an assay dependent concentration. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
|
|
IP |
1/50.
|
|
Dot blot |
1/1000.
|
特記事項 |
---|
WB
1/1000 - 1/5000. Predicted molecular weight: 72 kDa. |
IHC-P
Use at an assay dependent concentration. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
IP
1/50. |
Dot blot
1/1000. |
ターゲット情報
-
機能
Transcriptional activator; DNA-binding protein that specifically recognize the sequence 5'-YAAC[GT]G-3'. Plays an important role in the control of proliferation and differentiation of hematopoietic progenitor cells. -
配列類似性
Contains 3 HTH myb-type DNA-binding domains. -
ドメイン
Comprised of 3 domains; an N-terminal DNA-binding domain, a centrally located transcriptional activation domain and a C-terminal domain involved in transcriptional repression. -
翻訳後修飾
Ubiquitinated; mediated by SIAH1 and leading to its subsequent proteasomal degradation.
Phosphorylated by NLK on multiple sites, which induces proteasomal degradation. -
細胞内局在
Nucleus. - Information by UniProt
-
参照データベース
- Entrez Gene: 4602 Human
- Omim: 189990 Human
- SwissProt: P10242 Human
- Unigene: 606320 Human
-
別名
- C myb antibody
- c myb protein (140 AA) antibody
- c-myb protein (140 AA) antibody
see all
画像
-
All lanes : Anti-c-Myb (phospho S11) antibody [EP769Y] (ab45150) at 1/2000 dilution (purified)
Lane 1 : Molt-4 (Human lymphoblastic leukemia cell line) cell lysate with c-Myb (phospho S11) peptide
Lane 2 : Molt-4 cell lysate with c-Myb (phospho S12) peptide
Lane 3 : Molt-4 cell lysate with c-Myb (phospho S11/12) peptide
Lane 4 : Molt-4 cell lysate with c-Myb unmodified peptide
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : HRP goat anti-rabbit IgG (H+L) at 1/2000 dilution
Predicted band size: 72 kDa
Observed band size: 77 kDa why is the actual band size different from the predicted?
Exposure time: 30 secondsBlocking/Dilution buffer: 5% NFDM/TBST.
-
Immunohistochemical analysis of paraffin-embedded human vervical carcinoma tissue staining c-Myb with unpurified ab45150.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
-
Dot blot analysis of c-Myb (phospho S11/12) peptide (Lane 1) and c-Myb unmodified peptide (Lane 2) labeling c-Myb (phospho S11) with purified ab45150 at a dilution of 1/1000. ab97051 (Peroxidase conjugated goat anti-rabbit IgG (H+L)) was used as the secondary antibody at a dilution of 1/2500.
Blocking and dilution buffer: 5% NFDM/TBST.
Exposure time: 3 minutes.
-
All lanes : Anti-c-Myb (phospho S11) antibody [EP769Y] (ab45150) at 1/2000 dilution (purified)
Lane 1 : HeLa (Human epithelial cell line from cervix adenocarcinoma) cell lysate with c-Myc (phospho S11) peptide
Lane 2 : HeLa cell lysate with c-Myc (phospho S12) peptide
Lane 3 : HeLa cell lysate with c-Myc (phospho S11/12) peptide
Lane 4 : HeLa cell lysate with c-Myc unmodified peptide
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/20000 dilution (HRP goat anti-rabbit IgG (H+L))
Predicted band size: 72 kDa
Observed band size: 75,77 kDa why is the actual band size different from the predicted?Blocking/Dilution buffer: 5% NFDM/TBST.
-
All lanes : Anti-c-Myb (phospho S11) antibody [EP769Y] (ab45150) at 1/5000 dilution (purified)
Lane 1 : Untreated Ramos (Human Burkitt's lymphoma cell line) cell lysate
Lane 2 : Ramos cell lysate, membrane treated with alkaline phosphatase
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : HRP goat anti-rabbit IgG (H+L) at 1/2000 dilution
Predicted band size: 72 kDa
Observed band size: 75,77 kDa why is the actual band size different from the predicted?
Exposure time: 3 minutesBlocking/Dilution buffer: 5% NFDM/TBST.
-
All lanes : Anti-c-Myb (phospho S11) antibody [EP769Y] (ab45150) at 1/5000 dilution (purified)
Lane 1 : Untreated HL-60 (Human promyelocytic leukemia cell line) cell lysate
Lane 2 : HL-60 cell lysate, membrane treated with alkaline phosphatase
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : HRP goat anti-rabbit IgG (H+L) at 1/2000 dilution
Predicted band size: 72 kDa
Observed band size: 77 kDa why is the actual band size different from the predicted?
Exposure time: 3 minutesBlocking/Dilution buffer: 5% NFDM/TBST.
-
All lanes : Anti-c-Myb (phospho S11) antibody [EP769Y] (ab45150) at 1/2000 dilution (purified)
Lane 1 : HeLa cell lysate, the membrane treated with lambda phosphatase
Lane 2 : Untreated HeLa (Human epithelial cell line from cervix adenocarcinoma) cell lysate
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/5000 dilution (HRP goat anti-rabbit IgG (H+L))
Predicted band size: 72 kDa
Observed band size: 75,77 kDa why is the actual band size different from the predicted?
Exposure time: 30 secondsBlocking/Dilution buffer: 5% NFDM/TBST.
-
Anti-c-Myb (phospho S11) antibody [EP769Y] (ab45150) at 1/10000 dilution (unpurified) + Ramos (Human Burkitt's lymphoma cell line) membrane lysate
Predicted band size: 72 kDa
Observed band size: 72,75 kDa why is the actual band size different from the predicted? -
c-Myb was immunoprecipitated from 0.35 mg MOLT-4 (Human lymphoblastic leukemia T lymphoblast) whole cell lysate 10 µg with ab45150 at 1/120 dilution (2µg). VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1: MOLT-4 (Human lymphoblastic leukemia T lymphoblast) whole cell lysate 10 µg
Lane 2: ab45150 IP in MOLT-4 whole cell lysate
Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab45150 in MOLT-4 whole cell lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Fresh lysate should be used to minimize protein degradation. Multi-bands should be c-myb isoforms based on immunogen design and Uniprot database.
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (60)
ab45150 は 60 報の論文で使用されています。
- Smith C et al. TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer. Haematologica 108:1259-1271 (2023). PubMed: 36632736
- Deleuze V et al. Efficient genome editing in erythroid cells unveils novel MYB target genes and regulatory functions. iScience 26:107641 (2023). PubMed: 37670779
- Humtsoe JO et al. Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma. Cancers (Basel) 14:N/A (2022). PubMed: 35565392
- Parikh AS et al. Single-cell RNA sequencing identifies a paracrine interaction that may drive oncogenic notch signaling in human adenoid cystic carcinoma. Cell Rep 41:111743 (2022). PubMed: 36450256
- Ji J et al. Distinct clinicopathological and genomic features in solid and basaloid adenoid cystic carcinoma of the breast. Sci Rep 12:8504 (2022). PubMed: 35590093